Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer
Details for Australian Patent Application No. 2012100098 (hide)
International Classifications
Event Publications
16 February 2012 Innovation Patent Application Filed
1 March 2012 Innovation Patent Open to Public Inspection
Published as AU-A-2012100098
1 March 2012 Innovation Patent Sealed
12 April 2012 Application for Amendment
The nature of the amendment is: Amend the priority details to read 2010277373. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
2 August 2012 Amendment Made
The nature of the amendment is: Amend the divisional details to read 2010277373
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser